A New Frontier in the Fight Against Cancer
Cancer’s challenge and why SPARK is researching it in space?
Cancer’s challenge and why SPARK is researching it in space?
Allison Bajet, joined an exceptional group of internationally recognized space leaders at Frontiers Science House in Davos for the session “The Space Technology Revolution".
The clear ROI of orbital labs for oncology R&D.
SPARK Microgravity Brings Orbital Oncology Vision to ORBIT FOR LIFE Roundtable at Roche Diagnostics
SPARK Microgravity announces plans for Europe’s first commercial cancer lab in space at Frontiers Science House in Davos
How microgravity reveals truer tumor behavior than traditional models.
Two female founders are pioneering the next frontier in oncology.
Why microgravity transforms biomedical models for personalized medicine breakthroughs.
A beginner-friendly guide to understanding how SPARK Microgravity fits into the future of space.
How removing gravity reveals new insights in cancer research.
Unlocking Cancer’s Secrets in Microgravity
SPARK’s presence at Frontiers Science House reflects a broader momentum around the company as it continues to develop its orbital oncology platform.
Why space research is essential, not obsolete, for modern oncology.
Real case studies prove ROI of microgravity-enabled pharma innovation.
A data-driven look at the market for orbital oncology research.
Why 2D and animal models fail and how microgravity bridges translation.
How microgravity enables better drug design and novel therapeutic formulations.
SPARK Microgravity GmbH has clinched the top honor at the Barcelona Deep Tech Summit 2025, taking home the #1 EU Deep Tech Champion Award.
Step-by-step guide to launching your first microgravity research mission.
Meet the startup who won #1 EU Deep Tech Award 2025
SPARK Microgravity's co-founders share their space research mission during an interview at Barcelona Deep Tech Week 2025.
SPARK Microgravity Completes First Rocket Launch, Marking a Major Milestone Toward Orbital Cancer Research
SPARK Microgravity has successfully completed its integration campaign with Swedish Space Corporation (SSC).
How cancer's behavior in space reveals new therapeutic targets.
Solving "Undruggable" Targets with Perfect Crystals
How microgravity enables better drug design and novel formulations.
SPARK Microgravity’s leadership engaged with partners including Atmos Space Cargo, Space Cargo Unlimited, and Merck Sharp & Dohme (MSD)
Solving "Undruggable" Targets with Perfect Crystals
Unlocking Cancer’s Secrets in Microgravity
Cancer’s challenge and why SPARK is researching it in space?
The clear ROI of orbital labs for oncology R&D.
How microgravity enables better drug design and novel therapeutic formulations.
How removing gravity reveals new insights in cancer research.
Two female founders are pioneering the next frontier in oncology.
A data-driven look at the market for orbital oncology research.
A beginner-friendly guide to understanding how SPARK Microgravity fits into the future of space.
Why 2D and animal models fail and how microgravity bridges translation.
How microgravity reveals truer tumor behavior than traditional models.
Step-by-step guide to launching your first microgravity research mission.
Real case studies prove ROI of microgravity-enabled pharma innovation.
How cancer's behavior in space reveals new therapeutic targets.
How microgravity enables better drug design and novel formulations.
Why space research is essential, not obsolete, for modern oncology.
Why microgravity transforms biomedical models for personalized medicine breakthroughs.
From orbit to clinic, let’s launch the future of healthcare, together.
.svg)
